Tea Tree Oil
Also called Melaleuca alternifolia, melaleuca oil, tea tree essential oil, Melaleucae aetheroleum, terpinen-4-ol.
Best grade C across 7 graded outcomes Botanical Last checked
The short answer
From 14 sourcesTea tree oil is a topical essential oil. Small trials and a 2026 meta-analysis of 445 patients suggest a modest effect on mild to moderate acne, and single trials report benefits for dandruff and athlete's foot symptoms. It must never be swallowed: oral use can cause confusion and coma. Skin irritation and allergy are the usual side effects.
Every graded outcome on this page
7 rows · line = participants- CGrade CAcne severityAcnen 445
- CGrade CAthlete's foot (interdigital tinea pedis): clinical response and fungal clearanceAthlete's footn 158
- CGrade CDandruff severity (quadrant-area-severity score)Dandruffn 126
- CGrade CInflamed and non-inflamed acne lesions vs benzoyl peroxideAcnen 124
- CGrade CToenail fungus (onychomycosis) vs clotrimazoleNail fungusn 117
- CGrade CAthlete's foot: fungal clearance and symptoms vs tolnaftateAthlete's footn 104
- CGrade CAcne lesion count and severity indexAcnen 60
- 4 more graded outcomes, in the evidence chapter
Key facts
- What it is
- An essential oil steam-distilled from the leaves of Melaleuca alternifolia, mostly produced in Australia1
- Top studied outcome
- Acne severity: modestly lower than controls across 7 studies and 445 patients (pooled OR 0.74), grade C3
- Never swallow it
- Oral use can cause confusion, unsteadiness, inability to walk and coma; ingestion by a child is a medical emergency12
- Side effects
- Redness, itching, burning and allergic contact dermatitis; old or oxidised oil is more likely to irritate12
- Research quality
- A 2023 review of 46 randomized trials rated the evidence poor to modest overall; it was funded by AgriFutures Australia, a rural research body, and the tea tree industry association ATTIA gave access to its literature database10
What it is
Tea tree oil is the steam-distilled essential oil of the Australian Melaleuca alternifolia leaf, used only on the skin.
Forms, side by side
3 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Tea Tree Oil forms compared
3 forms| 3 forms | Gels, creams and washes (5% to 10%) | Shampoo (5%) | Concentrated or undiluted oil (25% to 100%) |
|---|---|---|---|
| Absorption in people | Applied to skin, not swallowed.1 | Applied to scalp and rinsed off.6 | Applied to skin or nails, not swallowed.2 |
| GI tolerance | Redness and irritation in some people; rare burn-like reactions are listed by the EU monograph.12 | No adverse effects in the 4-week dandruff trial.6 | Side effects were mostly minor in trials except at concentrations of 25% or more; 3.8% developed moderate to severe dermatitis with 25% to 50% solutions.710 |
| Studied for | Acne (5% gel), athlete's foot (10% cream) | Mild to moderate dandruff | Athlete's foot and toenail fungus |
- Gels, creams and washes (5% to 10%)
- Shampoo (5%)
- Concentrated or undiluted oil (25% to 100%)
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
7 graded outcomes, largest study first7 graded outcomes: 5 improved, 2 mixed. The largest, a 2026 meta-analysis of 445 people on acne severity, found an improvement.
1Acne severity
Improved · Grade C · Meta-analysis, 445 people, 2026
Patients with acne in 7 clinical studies
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Acne severity | Improved | 445 | Grade C · Meta-analysis, 2026 | Patients with acne in 7 clinical studies |
| Athlete's foot (interdigital tinea pedis): clinical response and fungal clearance | Improved | 158 | Grade C · RCT, 2002 | Patients with interdigital tinea pedis confirmed by microscopy (Australia) |
| Dandruff severity (quadrant-area-severity score) | Improved | 126 | Grade C · RCT, 2002 | People aged 14 and older with mild to moderate dandruff (Australia) |
| Inflamed and non-inflamed acne lesions vs benzoyl peroxide | Improved | 124 | Grade C · RCT, 1990 | Patients with mild to moderate acne (Australia) |
| Toenail fungus (onychomycosis) vs clotrimazole | Mixed | 117 | Grade C · RCT, 1994 | Patients with culture-proven distal subungual onychomycosis (U.S.) |
| Athlete's foot: fungal clearance and symptoms vs tolnaftate | Mixed | 104 | Grade C · RCT, 1992 | Patients with tinea pedis who completed the trial (Australia) |
| Acne lesion count and severity index | Improved | 60 | Grade C · RCT, 2007 | Adults with mild to moderate acne vulgaris (Iran) |
Every graded row
7 rowsShowing 7 of 7 outcomes. Human trials only.
CGrade CAcne severityAcnepooled OR 0.74Meta-analysis · 7 studies
n 445 · 2026
Improved Tea tree oil was associated with a modest reduction in acne severity compared with controls (pooled OR 0.74, 95% CI 0.63 to 0.88). Adverse events were mostly local and mild; the authors call for larger, standardized trials.
- Design
- Meta-analysis, 7 studies, n = 445, 2026
- Population
- Patients with acne in 7 clinical studies
- Form
- Topical tea tree oil preparations
- Dose
- Varied across studies
- Duration
- Varied
- Source
- Reference 3 · PubMed 42098589 (opens PubMed)
CGrade CAthlete's foot (interdigital tinea pedis): clinical response and fungal clearanceAthlete's footImprovedRCT
n 158 · 2002
Improved Marked clinical response in 72% (25%) and 68% (50%) vs 39% on placebo; fungal cultures turned negative in 64% with 50% oil vs 31% on placebo. Four patients (3.8%) on tea tree oil developed moderate to severe dermatitis that resolved after stopping.
- Design
- RCT, n = 158, 2002
- Population
- Patients with interdigital tinea pedis confirmed by microscopy (Australia)
- Form
- 25% or 50% tea tree oil solution vs placebo
- Dose
- Applied twice daily
- Duration
- 4 weeks
- Source
- Reference 7 · PubMed 12121393 (opens PubMed)
CGrade CDandruff severity (quadrant-area-severity score)DandruffImprovedRCT
n 126 · 2002
Improved Severity scores improved 41% with tea tree oil vs 11% with placebo (P < .001); itchiness and greasiness improved, scaliness did not reach significance. No adverse effects were reported.
- Design
- RCT, n = 126, 2002
- Population
- People aged 14 and older with mild to moderate dandruff (Australia)
- Form
- 5% tea tree oil shampoo vs placebo shampoo
- Dose
- Daily use
- Duration
- 4 weeks
- Source
- Reference 6 · PubMed 12451368 (opens PubMed)
CGrade CInflamed and non-inflamed acne lesions vs benzoyl peroxideAcneImprovedRCT
n 124 · 1990
Improved Both products reduced inflamed and non-inflamed lesions; tea tree oil acted more slowly but caused fewer side effects.
- Design
- RCT, n = 124, 1990
- Population
- Patients with mild to moderate acne (Australia)
- Form
- 5% tea tree oil gel vs 5% benzoyl peroxide lotion
- Dose
- 5% gel applied topically
- Duration
- Not stated in the abstract
- Source
- Reference 5 · PubMed 2145499 (opens PubMed)
CGrade CToenail fungus (onychomycosis) vs clotrimazoleNail fungusMixedRCT
n 117 · 1994
Mixed Results were similar and modest in both groups: negative fungal cultures 18% (tea tree oil) vs 11% (clotrimazole); partial or full clinical resolution 60% vs 61%.
- Design
- RCT, n = 117, 1994
- Population
- Patients with culture-proven distal subungual onychomycosis (U.S.)
- Form
- 100% tea tree oil vs 1% clotrimazole solution, with debridement
- Dose
- Applied twice daily
- Duration
- 6 months
- Source
- Reference 9 · PubMed 8195735 (opens PubMed)
CGrade CAthlete's foot: fungal clearance and symptoms vs tolnaftateAthlete's footMixedRCT
n 104 · 1992
Mixed Fungal cultures turned negative with tolnaftate in 85%, tea tree oil 30% and placebo 21% (tea tree oil no better than placebo). Scaling, inflammation, itching and burning improved more with tea tree oil than placebo.
- Design
- RCT, n = 104, 1992
- Population
- Patients with tinea pedis who completed the trial (Australia)
- Form
- 10% tea tree oil cream vs 1% tolnaftate vs placebo cream
- Dose
- 10% cream
- Duration
- Not stated in the abstract
- Source
- Reference 8 · PubMed 1303075 (opens PubMed)
CGrade CAcne lesion count and severity indexAcneImprovedRCT
n 60 · 2007
Improved Tea tree oil gel improved total lesion count and acne severity index significantly more than placebo (3.55 and 5.75 times more effective, respectively). Side effects were similar and tolerable in both groups.
- Design
- RCT, n = 60, 2007
- Population
- Adults with mild to moderate acne vulgaris (Iran)
- Form
- 5% tea tree oil gel vs placebo gel
- Dose
- 5% gel applied topically
- Duration
- 45 days
- Source
- Reference 4 · PubMed 17314442 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
Symptom relief is not the same as clearing fungus
In the 1992 athlete's foot trial, tea tree oil eased itching and scaling like tolnaftate but cleared the fungus no better than placebo.8
Low fungal clearance in nail fungus
After 6 months of twice-daily undiluted oil, fungal cultures were cleared in 18% of patients, against 11% with clotrimazole.9
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Interactions
0 agentsNone found in our sources.
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Tea Tree Oil and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Tea Tree Oil.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
7 groups- Swallowing or inhaling it
- Tea tree oil should never be swallowed, including mouthwashes that contain it; oral use can cause confusion, unsteadiness, inability to walk and coma. The EU monograph also rules out oral and inhaled use.12
- Children
- Use under 12 has not been established (EU monograph), and accidental ingestion by a child is a medical emergency needing hospital care. In published case reports, a 17-month-old became ataxic and drowsy after swallowing less than 10 mL, and a 4-year-old became unsteady within 30 minutes of swallowing a small amount, then unresponsive, and needed a breathing tube.21314
- Boys before puberty
- Breast enlargement in three otherwise healthy prepubertal boys coincided with repeated use of skin products containing lavender and tea tree oils and resolved after the products were stopped. LactMed notes numerous such reports in boys; their relevance has been questioned and not confirmed by further testing.1211
- Allergy to tea tree oil or colophony
- Contraindicated with hypersensitivity to tea tree oil or colophony (rosin). Stop if a rash develops.2
- Eyes and ears
- The EU monograph says not to use it in the eyes or ears.2
- Pregnancy and breastfeeding
- NCCIH says topical products may be safe during pregnancy and breastfeeding; the EU monograph, citing a lack of data, does not recommend use. LactMed reports no data in nursing mothers or infants and advises against applying it around the breast unless it is thoroughly removed before nursing. Oral use is never appropriate.1211
Safety
4 notesSkin-only use; swallowing it is dangerous.
- Skin reactions
- Smarting, itching, burning, redness, swelling and allergic contact dermatitis are reported; rare burn-like reactions occur.2
- Old oil
- Oxidised oil is more likely to sensitise skin; the EU monograph advises air-tight containers protected from light and heat.12
- Higher strengths
- Side effects in trials were minor except where the oil was used at 25% or higher.10
- Accidental ingestion
- Can cause central nervous system depression and muscle weakness; in children it requires immediate hospital care.2
How to read the label
What to check on the Supplement Facts panel.
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
7 answersDoes tea tree oil help acne?
Can tea tree oil be swallowed?
Does it work for athlete's foot or nail fungus?
Can tea tree oil cause breast growth in boys?
Does tea tree oil interact with medicines?
Why does tea tree oil irritate my skin?
Is tea tree oil shampoo useful for dandruff?
One 126-person trial found a 5% shampoo used daily for 4 weeks improved dandruff scores more than placebo (41% vs 11%). The trial was funded by a tea tree oil research institute.6
Sources
14 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
14 sources- 1Tea Tree Oil (last updated April 2025)Fact sheet NCCIH, 2025 · nccih.nih.gov
- 2European Union herbal monograph on Melaleuca alternifolia (Maiden and Betch) Cheel, M. linariifolia Smith, M. dissitiflora F. Mueller and/or other species of Melaleuca, aetheroleum (EMA/HMPC/320930/2012)Guideline European Medicines Agency (HMPC), 2015 · ema.europa.eu
- 3Efficacy and Safety of Melaleuca alternifolia (Tea Tree) Oil for Acne-A Systematic Review and Meta-Analysis.Meta-analysis Phytother Res, 2026 · PMID 42098589
- 4The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study.RCT Indian J Dermatol Venereol Leprol, 2007 · PMID 17314442
- 5A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne.RCT Med J Aust, 1990 · PMID 2145499
- 6Treatment of dandruff with 5% tea tree oil shampoo.RCT J Am Acad Dermatol, 2002 · PMID 12451368
- 7Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study.RCT Australas J Dermatol, 2002 · PMID 12121393
- 8Tea tree oil in the treatment of tinea pedis.RCT Australas J Dermatol, 1992 · PMID 1303075
- 9Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole.RCT J Fam Pract, 1994 · PMID 8195735
- 10Efficacy and safety of Melaleuca alternifolia (tea tree) oil for human health-A systematic review of randomized controlled trials.Systematic review Front Pharmacol, 2023 · PMID 37033604
- 11Tea Tree Oil. Drugs and Lactation Database (LactMed)Database National Institute of Child Health and Human Development, 2024 · ncbi.nlm.nih.gov
- 12Prepubertal gynecomastia linked to lavender and tea tree oils.Observational N Engl J Med, 2007 · PMID 17267908
- 13Melaleuca oil poisoning in a 17-month-old.Observational Vet Hum Toxicol, 1995 · PMID 8588296
- 14Ingestion of tea tree oil (Melaleuca oil) by a 4-year-old boy.Observational Pediatr Emerg Care, 2003 · PMID 12813303
What changed
Every dated change to this page: what changed, who made it and why.
Change log
3 entries| Date | Change | Who and why |
|---|---|---|
| who should be careful, insights, FAQ, related links, sources | Added LactMed (NBK501884, revised 2024) to the breastfeeding note; a 'boys before puberty' note from the 2007 case series (PMID 17267908); two child-ingestion case reports (PMIDs 8588296, 12813303); a medicines note and FAQ (EU monograph: no interactions reported; NCCIH lists none); a breast-growth FAQ; a nail-fungus insight; links to lavender and the hair and skin hub. Interaction table left empty after checking the EU monograph, NCCIH and LactMed. PubMed searched for 2023–2026 meta-analyses and RCTs: the 2026 acne meta-analysis remains the newest skin row; a 2024 gum-disease meta-analysis (PMID 38864380) and a 2023 Demodex meta-analysis (PMID 36310014) report no tea tree participant totals in their abstracts and were not added. Fact-checked against the sources; corrected: nail fungus insight now gives negative fungal cultures as 18% of patients, not of toenails; the medicines FAQ now reflects that NCCIH's advice is aimed at people taking medicines. | Writer: Kymata Health EditorialTrigger: A–Z page audit |
| all | Initial editorial evidence review (first draft). Every PMID checked against NCBI E-utilities esummary (title and year) and each cited abstract read; numbers taken from the abstracts. No retractions or errata linked to the cited PMIDs. Funding: the 2002 dandruff trial was funded by the Australian Tea Tree Oil Research Institute (stated in the journal article), and an institute researcher co-authored the 2002 athlete's foot trial; the 2026 meta-analysis was publicly funded. Safety, interaction and pregnancy text come only from NCCIH and the EMA herbal monograph (no interactions reported). No product links. | Writer: Kymata Health EditorialTrigger: new page |
| evidence and safety | Adversarial review: disclosed that the 2023 systematic review (PMID 37033604) was funded by AgriFutures Australia (grant PRJ-012616) with literature access from ATTIA Ltd; its authors declared no conflicts. | Writer: Kymata Health EditorialTrigger: adversarial review |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.